Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Safe Bulkers
SB
$881M
| $309K | ﹤0.01% |
173,755
-143,127
| -45% | -$324K |
|
|
AYX
3177
DELISTED
Alteryx Inc
AYX
| $309K | ﹤0.01% |
5,202
-9,917
| -66% | -$539K |
|
3178
Independence Realty Trust
IRT
$3.98B
| $308K | ﹤0.01% |
33,585
-8,251
| -20% | -$81.4K |
|
3179
Radiant Logistics
RLGT
$395M
| $308K | ﹤0.01% |
72,357
+60,722
| +522% | +$319K |
|
|
OPTN
3180
DELISTED
OptiNose
OPTN
| $307K | ﹤0.01% |
3,300
-3,832
| -54% | -$547K |
|
3181
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
| $307K | ﹤0.01% |
+9,300
| New | +$306K |
|
|
KDNY
3182
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $307K | ﹤0.01% |
23,275
+4,662
| +25% | +$93.1K |
|
3183
Clearwater Paper
CLW
$343M
| $305K | ﹤0.01% |
12,504
-3,098
| -20% | -$83.5K |
|
|
VCRA
3184
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $305K | ﹤0.01% |
+7,751
| New | +$280K |
|
|
ITIC
3185
Investors Title Co
ITIC
$562M
| $304K | ﹤0.01% |
+1,721
| New | +$307K |
|
3186
Algonquin Power & Utilities
AQN
$4.38B
| $303K | ﹤0.01% |
30,141
-42,187
| -58% | -$434K |
|
|
FENG
3187
Phoenix New Media
FENG
$17.7M
| $303K | ﹤0.01% |
15,777
+11,033
| +233% | +$226K |
|
3188
Superior Group of Companies
SGC
$203M
| $303K | ﹤0.01% |
17,148
+758
| +5% | +$13.7K |
|
3189
Neuronetics
STIM
$220M
| $303K | ﹤0.01% |
+15,679
| New | +$344K |
|
3190
Vanguard Real Estate ETF
VNQ
$39.3B
| $303K | ﹤0.01% |
4,070
-56,908
| -93% | -$4.48M |
|
3191
Flex
FLEX
$39.4B
| $301K | ﹤0.01% |
52,439
-274,292
| -84% | -$1.92M |
|
|
MYC
3192
DELISTED
Blackrock Muni Yield California Fund, Inc.
MYC
| $301K | ﹤0.01% |
+23,332
| New | +$296K |
|
3193
B&G Foods
BGS
$284M
| $300K | ﹤0.01% |
10,389
-67,062
| -87% | -$1.92M |
|
3194
Lennar Class B
LEN.B
$20.9B
| $300K | ﹤0.01% |
10,087
+2,491
| +33% | +$81.9K |
|
|
VER
3195
DELISTED
VEREIT, Inc.
VER
| $300K | ﹤0.01% |
8,405
-440,615
| -98% | -$16.4M |
|
3196
American Tower
AMT
$83.1B
| $299K | ﹤0.01% |
1,888
-1,020
| -35% | -$159K |
|
|
FTSV
3197
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $299K | ﹤0.01% |
19,000
-653
| -3% | -$9.97K |
|
3198
CALL
HealthEquity
HQY
$8.81B
| $298K | ﹤0.01% |
5,000
+2,000
| +67% | +$161K |
|
|
GORV
3199
DELISTED
Lazydays
GORV
| $297K | ﹤0.01% |
1,836
-456
| -20% | -$80.5K |
|
|
KANG
3200
DELISTED
iKang Healthcare Group, Inc.
KANG
| $296K | ﹤0.01% |
14,523
| – | – |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.